CVS Health is no investor’s idea of an exciting stock, but strong first-quarter results from the retail-and-insurance giant show that boring can be beautiful. Sales of $66.8 billion and adjusted earnings of $1.91 a share handily topped analyst expectations. The effects of Covid-19 boosted those earnings by 10 cents a share as shoppers refilled more prescriptions and bought more supplies at its stores as the pandemic arrived. Operating income in the retail business rose 42% from a year earlier.

Source: Wall Street Journal May 06, 2020 15:22 UTC